Stay updated on TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin

Sign up to get notified when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.
Latest website image capture
Clouds background image

Latest updates to the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision/version label has been updated from v3.5.2 to v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-25T17:53:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:16:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Minor formatting and textual adjustments observed; core study information such as eligibility criteria and primary endpoints remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-04T05:07:59.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The two screenshots show identical content and structure. No additions or deletions are present.
    Difference
    0.1%
    Check dated 2026-03-27T22:20:18.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.2%
    Check dated 2026-03-20T19:40:47.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:45:56.000Z thumbnail image

Stay in the know with updates to TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin

Enter your email address, and we'll notify you when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.